378 related articles for article (PubMed ID: 24304581)
1. Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma.
Chen L; Zhou S; Qin J; Hu H; Ma H; Liu B; Wang X; Ma J; Ye S; Zhong C; Zhou G; Liang C
Mol Cancer; 2013 Dec; 12(1):153. PubMed ID: 24304581
[TBL] [Abstract][Full Text] [Related]
2. Depletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunity.
Zhou S; Chen L; Qin J; Li R; Tao H; Zhen Z; Chen H; Chen G; Yang Y; Liu B; She Z; Zhong C; Liang C
PLoS One; 2013; 8(9):e73952. PubMed ID: 24023916
[TBL] [Abstract][Full Text] [Related]
3. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
4. Profile of regulatory T cells and interferon γ secretion in the tumor-draining lymph node from mouse Hepa1-6 cells.
Wang LK; Kuang M; Hua YP; He Q; Chen B; Wang Y; Peng BG
J Surg Res; 2013 Aug; 183(2):900-6. PubMed ID: 23481561
[TBL] [Abstract][Full Text] [Related]
5. Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.
Flanagan K; Glover RT; Hörig H; Yang W; Kaufman HL
Vaccine; 2004 Jul; 22(21-22):2894-903. PubMed ID: 15246626
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
7. Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo.
Sharma S; Stolina M; Luo J; Strieter RM; Burdick M; Zhu LX; Batra RK; Dubinett SM
J Immunol; 2000 May; 164(9):4558-63. PubMed ID: 10779757
[TBL] [Abstract][Full Text] [Related]
8. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.
Yu Y; Huang R; Zong X; He X; Mo W
BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats.
Wang GY; Zhang Q; Yang Y; Chen WJ; Liu W; Jiang N; Chen GH
Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):203-8. PubMed ID: 22484590
[TBL] [Abstract][Full Text] [Related]
10. Depletion of CD4(+)CD25(+) regulatory T cells can promote local immunity to suppress tumor growth in benzo[a]pyrene-induced forestomach carcinoma.
Chen YL; Fang JH; Lai MD; Shan YS
World J Gastroenterol; 2008 Oct; 14(38):5797-809. PubMed ID: 18855977
[TBL] [Abstract][Full Text] [Related]
11. The anti-tumor effect and increased tregs infiltration mediated by rAAV-SLC vector.
Li R; Hu H; Ma H; Chen L; Zhou B; Liu Y; Liang C
Mol Biol Rep; 2013 Oct; 40(10):5615-23. PubMed ID: 24078089
[TBL] [Abstract][Full Text] [Related]
12. Local expression of secondary lymphoid tissue chemokine delivered by adeno-associated virus within the tumor bed stimulates strong anti-liver tumor immunity.
Liang CM; Zhong CP; Sun RX; Liu BB; Huang C; Qin J; Zhou S; Shan J; Liu YK; Ye SL
J Virol; 2007 Sep; 81(17):9502-11. PubMed ID: 17567706
[TBL] [Abstract][Full Text] [Related]
13. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.
Chen X; Du Y; Huang Z
Immunol Lett; 2012; 148(1):83-9. PubMed ID: 23000301
[TBL] [Abstract][Full Text] [Related]
14. Decreased suppression of CD8
Giri PS; Dwivedi M; Begum R
Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency and FOXP3 expression of human CD8
Zahran AM; Nafady-Hego H; Mansor SG; Abbas WA; Abdel-Malek MO; Mekky MA; Hetta HF
Hum Immunol; 2019 Jul; 80(7):510-516. PubMed ID: 30904437
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral administration of secondary lymphoid chemokine and unmethylated cytosine-phosphorothioate-guanine oligodeoxynucleotide synergistically inhibits tumor growth in vivo.
Oh SM; Oh K; Lee DS
J Korean Med Sci; 2011 Oct; 26(10):1270-6. PubMed ID: 22022177
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity.
Yang SC; Hillinger S; Riedl K; Zhang L; Zhu L; Huang M; Atianzar K; Kuo BY; Gardner B; Batra RK; Strieter RM; Dubinett SM; Sharma S
Clin Cancer Res; 2004 Apr; 10(8):2891-901. PubMed ID: 15102698
[TBL] [Abstract][Full Text] [Related]
18. Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice.
Satoh Y; Esche C; Gambotto A; Shurin GV; Yurkovetsky ZR; Robbins PD; Watkins SC; Todo S; Herberman RB; Lotze MT; Shurin MR
J Exp Ther Oncol; 2002; 2(6):337-49. PubMed ID: 12440225
[TBL] [Abstract][Full Text] [Related]
19. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
20. Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio.
Azzimonti B; Zavattaro E; Provasi M; Vidali M; Conca A; Catalano E; Rimondini L; Colombo E; Valente G
Br J Dermatol; 2015 Jan; 172(1):64-73. PubMed ID: 24910265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
